美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Franklin Genomic Advancements ETF

41.83

+0.23370.56%

成交量：208

成交額：8,673.70

市值：3,137.05萬

市盈率：- -

高：41.83

開：41.59

低：41.83

收：41.59

52周最高：43.51

52周最低：29.80

股本：75.00萬

流通股本：75.00萬

量比：0.38

換手率：0.03%

股息：0.14

股息率：0.34%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Guardant Health與Evernorth旗下Evicore達成協議，Shield血液檢測自2027年1月1日起納入結直腸癌篩查覆蓋範圍

阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。

港股生物技術板塊午後拉升

南方财经网

港股生物技術板塊午後拉升，劑泰科技漲近13%，百奧賽圖升逾8%，雲頂新耀、基石藥業升逾4%。

Guardant Health重磅里程碑：Guardant360® Cdx獲FDA批准，成為阿斯利康Ectamah™（Camizestrant）晚期乳腺癌伴隨診斷

普洛藥業等成立生物技術公司

上海：「十五五」時期將推動增值電信、生物技術、獨資醫院等開放項目落地

Dr.Ross Crittenden：生物技術賦能可持續生產，打造精準匹配全生命周期需求的高品質營養解決方案

美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極

澳大利亞全球性生物技術公司 CSL：與美國政府達成協議，下調藥品價格並支持美國本土生產領域投資。相關協議旨在降低 CSL

美國總統特朗普在聲明中提到了全球性腫瘤藥企BeOne Medicines和澳大利亞全球性生物技術公司 CSL。

Natera攜手Susan G. Komen® 共推乳腺癌防治新篇章

福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設

福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設

醫保病理雲統一索引正式落地一碼互通賦能精準醫療

醫保病理雲統一索引正式落地一碼互通賦能精準醫療

美國法院在DNA測序專利糾紛案中裁定Guardant公司支付2.45億美元

Twinstrand：法院判決公司及Uw獲賠逾2.452億美元，涵蓋截至2026年5月31日的侵權損害賠償、應計特許權使用費及利息

Twinstrand勝訴：法院維持2023年故意侵權判決，並裁定Guardant Health 11項產品與服務須支付6%特許權使用費

Twinstrand案判決：Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/HELX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":41.8273,"timestamp":1789502400000,"preClose":41.5936,"halted":0,"volume":208,"delay":0,"changeRate":0.005618652869672231,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"盤前交易","change":0.2337,"latestTime":"09-16 05:55:10 EDT","open":41.5936,"high":41.8273,"low":41.8273,"amount":8673.69984,"amplitude":0,"askPrice":66.5,"askSize":100,"bidPrice":16.82,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":41.8273,"sharesOutstanding":650000,"nav":41.622,"aum":31216701.03,"dividendRate":0.003381,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.5936,"preClose":41.8273,"latestTime":"19:30 EDT","volume":8,"amount":334.151,"timestamp":1789515006138,"change":-0.2337,"changeRate":-0.005587,"amplitude":0},"volumeRatio":0.38490008114174834,"impliedVol":0.0896,"impliedVolPercentile":0.344},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.38490008114174834,"shares":750000,"dividePrice":0.1414,"high":41.8273,"amplitude":0,"preClose":41.5936,"low":41.8273,"week52Low":29.8,"pbRate":"--","week52High":43.5089,"institutionHeld":0,"latestPrice":41.8273,"eps":0,"divideRate":0.003381,"volume":208,"delay":0,"ttmEps":0,"open":41.5936,"prevYearClose":36.3062,"prevWeekClose":40.9874,"prevMonthClose":41.805,"prevQuarterClose":39.9651,"fiveDayClose":41.6426,"twentyDayClose":41.1366,"sixtyDayClose":35.8162},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1103100254","title":"Guardant Health與Evernorth旗下Evicore達成協議，Shield血液檢測自2027年1月1日起納入結直腸癌篩查覆蓋範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=1103100254","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103100254?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 04:08","pubTimestamp":1789416490,"startTime":"0","endTime":"0","summary":"Guardant Health公司宣布，Evernorth旗下的Evicore已决定将其Shield血液检测纳入结直肠癌（CRC）筛查的承保范围。这项覆盖计划将于2027年1月1日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","BK4588","EKG","PTH","HELX","LFSC","GNOM","GNMX","LU0320765992.SGD","BK4585","LU0889565916.HKD","GH","LU0109394709.USD","GDOC","BK4196","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FBT","HELX","IDNA","RXL","LU2272731600.USD","AZNH","BME","IEHS","BK4585","LU2473716301.USD","IEIH","PPH","LU2272731782.SGD","XBIX","LU2322448791.USD","SYNB","LU2322448957.HKD","LU1992135472.HKD","PJP","MRNY","LU2272731865.HKD","MEDI","IBRN","RSPH","PBE","TMED","GNOM","PBPH","BBP","IBB","BBH","CANC","BK4588","BIB","XPH","BIOY","FTXH","MRNX","IE00B5TLWC47.USD","SBIO","LFSC","PSCH","LU1992135399.USD","WDNA","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665426123","title":"港股生物技術板塊午後拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2665426123","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665426123?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:31","pubTimestamp":1788845460,"startTime":"0","endTime":"0","summary":"南方财经9月8日电，港股生物技术板块午后拉升，剂泰科技涨近13%，百奥赛图涨超8%，云顶新耀、基石药业涨超4%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609083867927161.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609083867927161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","KCAI","BK4588","HELX","WDNA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665428723","title":"港股生物技術板塊午後拉升，劑泰科技漲近13%，百奧賽圖升逾8%，雲頂新耀、基石藥業升逾4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665428723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665428723?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:28","pubTimestamp":1788845318,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","KCAI","HELX","BK4585","VXUS","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116354483","title":"Guardant Health重磅里程碑：Guardant360® Cdx獲FDA批准，成為阿斯利康Ectamah™（Camizestrant）晚期乳腺癌伴隨診斷","url":"https://stock-news.laohu8.com/highlight/detail?id=1116354483","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116354483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 06:11","pubTimestamp":1788559873,"startTime":"0","endTime":"0","summary":"Guardant Health今日宣布，其Guardant360 Cdx液体活检产品已获得美国食品药品监督管理局的里程碑式批准，正式成为阿斯利康新型内分泌疗法Ectamah在晚期乳腺癌治疗中的伴随诊断工具。Guardant Health管理层在声明中表示，这一里程碑不仅是对公司技术实力的权威认可，更是对癌症患者个体化治疗承诺的有力践行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","EKG","GNOM","BK4535","LU0320765992.SGD","LU0889565916.HKD","BK4196","LU0109394709.USD","GDOC","BK4551","PTH","BK4588","GH","HELX","FFOX","BK4585","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826603","title":"普洛藥業等成立生物技術公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826603","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664826603?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 15:26","pubTimestamp":1788506762,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WDNA","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664255128","title":"上海：「十五五」時期將推動增值電信、生物技術、獨資醫院等開放項目落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2664255128","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664255128?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 11:37","pubTimestamp":1788406675,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["HELX","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818969","title":"Dr.Ross Crittenden：生物技術賦能可持續生產，打造精準匹配全生命周期需求的高品質營養解決方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818969","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818969?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 17:54","pubTimestamp":1788342840,"startTime":"0","endTime":"0","summary":"本次大会由中国营养学会精准营养产业分会主办。Dr.Ross Crittenden：当中国致力于提升质量和规模来满足蛋白质供应需求时，一旦下定决心，行动总是非常迅速且出色。Dr.Ross Crittenden：婴儿营养是一个很好的例子，既要提供所需的优质蛋白质，还要提供像母乳低聚糖这类成分。通过应用来自自然的生物解决方案，能够将这些蛋白质融入更广泛的食品中，并使其具备所需的功能特性，并且确保食品的美味口感。Dr.Ross Crittenden：诺和新元与中国产业的合作已有超过三十年的历史。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/meeting/2026-09-02/doc-iniqmshw2842845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["WDNA","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664521258","title":"美股異動丨諾華製藥升逾7%，多發性硬化症口服藥後期臨床試驗結果積極","url":"https://stock-news.laohu8.com/highlight/detail?id=2664521258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664521258?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 22:18","pubTimestamp":1788272338,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LFSC","IE00B4R5TH58.HKD","LU2322448957.HKD","IE00BJJMRZ35.SGD","BIB","MEDX","BK4588","XPH","IDNA","IE0002141913.USD","RSPH","RXL","PBPH","IBRN","BBP","IE00BJT1NW94.SGD","MRNX","FBT","XBIX","BIOY","BK4585","SBIO","AZNH","PJP","MEDI","TMED","IE00BFTCPJ56.SGD","LU0211331839.USD","HELX","IEIH","FTXH","IBB","LU0070302665.USD","MRNY","IE0009355771.USD","PBE","BK4007","PPH","IEHS","BBH","SYNB","WDNA","CANC","NVS","PSCH","LU2473716301.USD","LU2272731600.USD","BME","IYH","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000019","title":"澳大利亞全球性生物技術公司 CSL：與美國政府達成協議，下調藥品價格並支持美國本土生產領域投資。相關協議旨在降低 CSL","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000019","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000019?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:25","pubTimestamp":1788204343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["WDNA","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002090","title":"美國總統特朗普在聲明中提到了全球性腫瘤藥企BeOne Medicines和澳大利亞全球性生物技術公司 CSL。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002090","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002090?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 03:10","pubTimestamp":1788203427,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["WDNA","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165686021","title":"Natera攜手Susan G. Komen® 共推乳腺癌防治新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1165686021","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165686021?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 23:07","pubTimestamp":1787929655,"startTime":"0","endTime":"0","summary":"Natera与Susan G. Komen®共同宣布，双方将建立全国性合作伙伴关系，旨在加速推动乳腺癌防治领域的进展。这一战略联盟汇聚了精准医疗领域的先锋力量与全球知名的乳腺癌公益组织，有望为患者带来更为精准、高效的诊疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0012050646.USD","LU2065171402.SGD","LU2065171311.SGD","LU0345770993.USD","LU2065170008.USD","LU1064131342.USD","LU2264538146.SGD","LU0963586101.USD","LU0106261612.USD","LU0053671581.USD","BK4139","LU2324357040.USD","LU2065169927.USD","LU0345770308.USD","LU1988902786.USD","HELX","NTRA","GNOM","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775292","title":"福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775292","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775292?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:49","pubTimestamp":1787813340,"startTime":"0","endTime":"0","summary":"格隆汇8月27日丨今日，《福建省“十五五”卫生健康发展规划》印发。其中提到，深化卫生健康两岸融合发展，构建跨区域开放发展新格局。加强两岸医疗健康产业合作，推动闽台在生物医药研发、重大疾病防控、前沿医疗技术研究等领域交流合作。支持海峡两岸生物技术和医疗健康产业合作区建设。深化闽台医药融合，鼓励引进台湾地区已上市的高临床价值创新药械在本省医疗机构应用。支持福建中医药大学建设闽台融合中医药重点实验室。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2026-08-27/doc-inipttav9117970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IXJ","WDNA","VHT","HELX","XLV","BK4588","BK4581","BK4550","159760","XBI","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662077593","title":"福建：擬支持海峽兩岸生物技術和醫療健康產業合作區建設","url":"https://stock-news.laohu8.com/highlight/detail?id=2662077593","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662077593?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:45","pubTimestamp":1787813117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4588","VHT","BK4550","WDNA","XLV","HELX","IXJ","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662832764","title":"醫保病理雲統一索引正式落地 一碼互通賦能精準醫療","url":"https://stock-news.laohu8.com/highlight/detail?id=2662832764","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662832764?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 11:29","pubTimestamp":1787714956,"startTime":"0","endTime":"0","summary":"本次发布的医保病理云索引共设8个部分，总长79位，涵盖全维度核心检查信息，要素全面、精准可溯。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KOMP","SYNB","WDNA","GDOC","DTEC","GNMX","IDNA","BMED","HELX","TYNE","HTEC","XT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662648607","title":"醫保病理雲統一索引正式落地 一碼互通賦能精準醫療","url":"https://stock-news.laohu8.com/highlight/detail?id=2662648607","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662648607?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 11:29","pubTimestamp":1787714956,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SYNB","HELX","IDNA","BMED","TYNE","HTEC","WDNA","XT","GDOC","DTEC","GNMX","GNOM","KOMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661227372","title":"美國法院在DNA測序專利糾紛案中裁定Guardant公司支付2.45億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661227372","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661227372?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:21","pubTimestamp":1787570491,"startTime":"0","endTime":"0","summary":"美国法院在DNA测序专利纠纷案中裁定Guardant公司支付2.45亿美元路透8月24日-TwinStrand Biosciences周一表示，美国一家法院裁定Guardant Health公司侵犯了涉及DNA测序技术的专利，并责令其向TwinStrand Biosciences和华盛顿大学支付超过2.452亿美元的赔偿金。法院裁定，Guardant必须就其11项被认定侵犯专利的产品及服务在美国的销售额，支付6%的专利使用费，直至2033年3月相关专利到期为止。TwinStrand表示，该判决所涵盖的产品和服务约占Guardant在侵权期间总收入的90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4T44L0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","BK4535","GNMX","PTH","LU0889565916.HKD","BK4585","GH","LFSC","EKG","GDOC","GNOM","LU0109394709.USD","LU0320765992.SGD","BK4551","BK4196","FFOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160211496","title":"Twinstrand：法院判決公司及Uw獲賠逾2.452億美元，涵蓋截至2026年5月31日的侵權損害賠償、應計特許權使用費及利息","url":"https://stock-news.laohu8.com/highlight/detail?id=1160211496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160211496?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:01","pubTimestamp":1787569302,"startTime":"0","endTime":"0","summary":"Twinstrand公告，法院已作出裁决，判令公司及Uw获得超过2.452亿美元的赔偿金。这笔款项涵盖了截至2026年5月31日期间所发生的侵权损害、累积的特许权使用费以及相应利息。\n裁决金额之巨，彰显了司法体系对知识产权保护的坚定立场。赔偿总额精确计算至该截止日期，包括了多层次的补偿要素。侵权行为的认定范围，则明确划定在2026年5月31日之前发生的全部相关行为。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","EKG","GNOM","LU0109394709.USD","BK4535","LU0889565916.HKD","LU0320765992.SGD","BK4551","LFSC","BK4196","BK4585","GDOC","GNMX","BK4588","FFOX","PTH","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194764905","title":"Twinstrand勝訴：法院維持2023年故意侵權判決，並裁定Guardant Health 11項產品與服務須支付6%特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1194764905","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194764905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:01","pubTimestamp":1787569276,"startTime":"0","endTime":"0","summary":"法院裁定，维持2023年关于故意侵权的判决，同时要求Guardant Health公司就其11项产品及服务所产生的销售额，向Twinstrand支付6%的特许权使用费。这一裁决意味着，Twinstrand在知识产权纠纷中取得了关键性胜利。对于Guardant Health而言，这项决定无疑构成了财务上的重大负担。Twinstrand方面则对这一结果表示认可。此次6%特许权使用费的设定，亦反映了法院对此类行为的态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","LFSC","BK4196","BK4551","GNOM","LU0320765992.SGD","FFOX","GH","HELX","LU0889565916.HKD","EKG","GNMX","PTH","BK4535","LU0109394709.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127912643","title":"Twinstrand案判決：Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細","url":"https://stock-news.laohu8.com/highlight/detail?id=1127912643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127912643?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"根据Twinstrand方面的消息，法院判决要求Guardant Health必须履行一项新的义务——按季度提交其在美国市场上全部11款产品与服务的销售账目，以供公司与承销商查阅。\n这一判决意味着，Guardant Health在运营透明度和合规性上将面临更为严格的监督。具体而言，公司需定期整理并呈报相关销售数据，确保各方能够及时掌握其业务动态。\n此举无疑为市场参与者提供了更清晰的视角，去审视这家精准医疗领域领军企业的真实业绩表现。季度汇报机制的建立，或将进一步影响投资者对该公司未来走势的评估与判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","BK4196","HELX","PTH","GNOM","LFSC","EKG","BK4535","LU0320765992.SGD","LU0889565916.HKD","BK4588","FFOX","BK4585","BK4551","LU0109394709.USD","GH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}]}}